Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
US7173004B2 · kind B2 · utility
47Cited by
2References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2004 |
| Grant date | Feb 6, 2007 |
| Priority date | — |
| Expiry date | Aug 24, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Macrocyclic isoquinoline peptides are disclosed having the general formula:A compound of formula I:wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.